Results 61 to 70 of about 10,565,775 (206)

5‐Methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) for alcohol use disorder: An open‐label, phase 2, proof‐of‐concept, clinical trial

Addiction, EarlyView.
Abstract Background and Aims Psychedelic drugs may help treat alcohol use disorder (AUD). This study evaluated BPL‐003, a novel intranasal powder formulation of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) benzoate salt, in people with moderate–severe AUD enrolled in a standard of care, 10‐week programme of relapse‐prevention oriented Cognitive ...
John Marsden, Michael Kelleher, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, Claire Roberts, James J. Rucker, Gemma Scott, Ivan Saeger, Francesca Small, Mathieu Seynaeve   +10 more
wiley   +1 more source

Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample

Frontiers in Psychiatry, 2023
ObjectiveIn recent years, there has been a renewed interest in investigating the use of classic psychedelics such as psilocybin and lysergic acid diethylamide (LSD) in the treatment of mental disorders and substance use disorders.
Tor-Morten Kvam, Tor-Morten Kvam, Malin V. Uthaug, Malin V. Uthaug, Malin V. Uthaug, Kristoffer A. A. Andersen, Kristoffer A. A. Andersen, Birk Berggrav Refsum, Paula Aarseth Tunstad, Lowan Han Stewart, Henrik Børsting Jacobsen, Henrik Børsting Jacobsen, Cato Grønnerød   +12 more
doaj   +1 more source

Trends in new psychoactive substance poisonings in the Netherlands: A 14‐year retrospective analysis (2012–2025)

Addiction, EarlyView.
Abstract Background and aims Data on the presence of new psychoactive substances (NPS) mainly originate from drug‐checking, law enforcement and wastewater analysis sources, while data on NPS poisonings are scarce. In Europe, the documented incidence rate of NPS poisonings is highest in the Netherlands.
Johanna J. Nugteren‐van Lonkhuyzen, Irma S. van den Hengel‐Koot, Claudine C. Hunault, Dylan W. de Lange, Antoinette J. H. P. van Riel, Laura Hondebrink   +5 more
wiley   +1 more source

PINZOTE de Musa balbisiana y Musa acuminata como Fuente de Fibras para Papel [PDF]

, 2009
Este trabajo presenta una alternativa de uso industrial del pinzote (centro le oso del racimo de banano) como fuente de fibra para la estructuraci n de papel.
Turrado, Jos�, Sanju�n, Rub�n, Turrado, José, Saucedo, Alma R, Sanjuán, Rubén, Sulbaran, Belkis   +5 more
core   +1 more source

Psychological change processes in alcohol use disorder: A qualitative study of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT) with cognitive behavioural therapy

Addiction, EarlyView.
Abstract Background and aims This study qualitatively explored psychological change processes as described by participants and therapists within a phase 2a clinical trial evaluating the safety, tolerability, and preliminary efficacy of a single dose of intranasal 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT; BPL‐003) administered alongside psychological
Mathieu Seynaeve, Fiona Dunbar, Anna O. Ermakova, Luke Mitcheson, James J. Rucker, Anthony Cleare, John Marsden   +6 more
wiley   +1 more source

Updated View on the Relation of the Pineal Gland to Autism Spectrum Disorders

Frontiers in Endocrinology, 2019
Identification of the biological features of autism is essential for designing an efficient treatment and for prevention of the disorder. Though the subject of extensive research, the neurophysiological features of autism remain unclear.
Tal Shomrat, Nir Nesher
doaj   +1 more source

Resolución CSPyGE N° 18/2021. Derogar la Resolución CSPyGE N° 97/2019 y su modificatoria, Resolución CSPyGE N° 02/2021. Aprobar el Régimen de Personal Docente. [PDF]

, 2021
Fil: Consejo Superior de Programación y Gestión Estratégica (P). Universidad Nacional de Río Negro. Río Negro, ArgentinaResolución CSPyGE N° 18/2021. Derogar la Resolución CSPyGE N° 97/2019 y su modificatoria, Resolución CSPyGE N° 02/2021.
Consejo Superior de Programación y Gestión Estratégica (P)
core  

N/A [PDF]

, 1926
N/AEn los últimos años se ha empezado a notar la preocupación del gobierno por la creación de puesto veterinarios municipales que velan por el estado de salud de las carnes de consumo , la publicación de varis acuerdos tendientes a higienizar las ...
Mejía, Santiago
core  

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review

Clinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 94-108, July 2026.
Interest in ayahuasca and its main component, N,N‐Dimethyltryptamine (DMT), has currently moved from historical and experimental use into modern clinical development. Yet, current evidence is fragmented, and systematic mapping of trial methods and design choices remains limited.
Tijana Stojanović, Kent W. Nilsson, Robert Fredriksson, Helgi B. Schiöth, Thiago C. Moulin   +4 more
wiley   +1 more source

Predicting drug–drug interactions between ayahuasca alkaloids and SSRIs using physiologically based pharmacokinetic modeling

Frontiers in Molecular Biosciences
IntroductionAyahuasca is a psychedelic preparation containing N,N-dimethyltryptamine (DMT) and the β-carboline harmine (HRM), a reversible monoamine oxidase A inhibitor that enables DMT oral bioavailability.
Gabriella de Souza Gomes Ribeiro, Beatriz Aparecida Passos Bismara Paranhos, Fabiane Dörr, Maurício Yonamine, Bianca Villanova, Lorena Terene Lopes Guerra, Adrieli Oliveira Raminelli, Jose Augusto Silva Reis, Caio Cesar de Paula, Anna Beatriz Vicentini Zacharias, Jaime Eduardo Cecílio Hallak, Jaime Eduardo Cecílio Hallak, Rafael Guimarães dos Santos, Rafael Guimarães dos Santos, Frederico Severino Martins, Tania Marcourakis   +15 more
doaj   +1 more source